Literature DB >> 29334810

Monitoring of Metabolic Adverse Effects Associated With Atypical Antipsychotics Use in an Outpatient Psychiatric Clinic.

Luis Pereira1, Aliaksandr Budovich1, Maria Claudio-Saez1.   

Abstract

BACKGROUND: Atypical antipsychotics are associated with metabolic complications that contribute to a higher risk of cardiovascular disease. Current evidence reveal suboptimal adherence to the complex and variable official recommendations on metabolic monitoring in the corresponding patient population. A study evaluating metabolic monitoring at guideline-recommended intervals may help identify areas for intervention.
OBJECTIVE: Describe the frequency of monitoring metabolic adverse effects in patients receiving atypical antipsychotics in an outpatient psychiatric clinic with respect to the specific guideline-recommended intervals.
METHODS: A retrospective chart review was conducted in the outpatient psychiatric clinic. The primary outcome measure was the percentage of patients monitored for metabolic parameters at the current guideline-recommended intervals. The secondary end points were the percentage of patients with documented primary care physician, untreated metabolic comorbidities, and treated metabolic comorbidities by disease state.
RESULTS: The most assessed parameters were family history (98%), blood pressure (81%), and body mass index/body weight (83%) at the baseline interval. The least assessed parameters were lipids (14%) at the 12-week interval and waist circumference (0%) at any interval.
CONCLUSION: Interventions are needed to encourage higher compliance with current recommendations. The complexity of the recommendations is the most likely reason for the suboptimal compliance.

Entities:  

Keywords:  antipsychotic; atypical; metabolic; monitoring; second generation

Mesh:

Substances:

Year:  2018        PMID: 29334810     DOI: 10.1177/0897190017752712

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  5 in total

1.  Compliance with the guidelines for laboratory monitoring of patients treated with lithium: A retrospective follow-up study among ambulatory patients in the Netherlands.

Authors:  Mariëtte Nederlof; Toine Cg Egberts; Liesbeth van Londen; Maurits Cfj de Rotte; Patrick C Souverein; Ron Mc Herings; Eibert R Heerdink
Journal:  Bipolar Disord       Date:  2019-01-02       Impact factor: 6.744

2.  Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics.

Authors:  Lenneke Minjon; Ivona Brozina; Toine C G Egberts; Eibert R Heerdink; Els van den Ban
Journal:  Front Psychiatry       Date:  2021-02-25       Impact factor: 4.157

3.  Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study.

Authors:  Silvana Galderisi; Marc De Hert; Stefano Del Prato; Andrea Fagiolini; Philip Gorwood; Stefan Leucht; Aldo Pietro Maggioni; Armida Mucci; Celso Arango
Journal:  Eur Psychiatry       Date:  2021-01-08       Impact factor: 5.361

4.  Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal.

Authors:  Andrea Fiorillo; Norman Sartorius
Journal:  Ann Gen Psychiatry       Date:  2021-12-13       Impact factor: 3.455

5.  The Complex Interplay Between Physical Activity and Recovery Styles in Patients With Severe Mental Disorders in a Real-World Multicentric Study.

Authors:  Gaia Sampogna; Mario Luciano; Matteo Di Vincenzo; Ileana Andriola; Enrico D'Ambrosio; Mario Amore; Gianluca Serafini; Alessandro Rossi; Claudia Carmassi; Liliana Dell'Osso; Giorgio Di Lorenzo; Alberto Siracusano; Rodolfo Rossi; Andrea Fiorillo
Journal:  Front Psychiatry       Date:  2022-07-11       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.